Skip to main content
. 2022 Nov 9;31(11):1645–1654. doi: 10.1089/jwh.2022.0004

Table 2.

Distribution of Midlife Reproductive Outcomes in Midlife Women's Health Study Subsample (N = 101)

  n (%) or median (25th, 75th percentiles)
Hot flashes
 Ever had hot flashes
  Never had hot flashes 54 (53.5)
  Ever had hot flashes 47 (46.5)
 Had hot flashes in the past 30 days
  Never had hot flashes 54 (53.5)
  Had hot flashes but not in the past 30 days 18 (17.8)
  Had hot flashes in the past 30 days 29 (28.7)
 Hot flash frequency (2 missing)a
  Never had hot flashes 54 (53.5)
  Had daily/weekly hot flashes 24 (23.8)
  Had monthly hot flashes 21 (20.8)
 Hot flash severity (1 missing)a
  Never had hot flashes 54 (53.5)
  Had mild hot flashes 16 (15.8)
  Had moderate/severe hot flashes 30 (29.7)
Hormonesb
  Estradiol, pg/mL 50.1 (28.9, 72.5)
  Testosterone, ng/mL 0.3 (0.2, 0.4)
  Progesterone, ng/mL 0.8 (0.3, 1.5)
  SHBG, nmol/L 81.7 (56.8, 102.8)
  FSH, mIU/mL 8.9 (4.8, 50.2)
  AMH, ng/mL 0.1 (0.1, 0.8)
Ovarian volume
  Ovarian volume, cm3 (10 missing)c 4.5 (2.3, 6.1)
a

Values may not add up to 100% because of missing information.

b

LOQ of assays are detailed in Chiang et al.26

c

One woman was excluded owing to having ovarian volume >30 cm3, whereas the remaining nine women were missing ovarian volume values.

AMH, anti-Müllerian hormone; FSH, follicle-stimulating hormone; LOQ, limit of quantification; SHBG, sex hormone binding globulin.